Expert-led presentations & discussions on key abstracts in ALL from ASH 2022
The Post-ASH 2022 iwAL Virtual Workshop was held on 11-12 January 2023, with a packed program covering acute myeloid leukemia (AML) on Day 1, and acute lymphoblastic leukemia (ALL) on Day 2. Both days featured a series of short presentations on selected abstracts from the 64th ASH Annual Meeting presented by experts with interactive panel discussions after each session.
Session 1: MRD-led treatment outcomes and considerations for multi-agent chemotherapy
Session 2: Targeted treatments in B-cell ALL – blinatumomab
Session 3: Targeted treatments in B-cell ALL – inotuzumab ozogamicin
Session 4: Current clinical updates for CAR-T in B-ALL
Session 5: Clinical strategy updates for patients with Ph+/like ALL
The continued success of the iwAL meeting is in no small part due to the ongoing funding of supporters, allowing a unique opportunity for clinicians to be brought together to facilitate interactive and stimulating debates to help improve patient outcomes.
For more information about supporting future iwAL meetings and activities, please contact us here.
For the latest updates in ALL, visit The ALL Channel
By choosing to continue, you are confirming that you are a healthcare professional
Keep up to date with all the latest news with our monthly newsletter